Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.40
Bid: 105.20
Ask: 105.40
Change: -0.80 (-0.76%)
Spread: 0.20 (0.19%)
Open: 105.20
High: 105.80
Low: 104.40
Prev. Close: 104.40
BSIF Live PriceLast checked at -
Bluefield Solar Income Fund is an Investment Trust

To provide Shareholders with an attractive return, principally in the form of quarterly income distributions by being invested primarily in solar energy assets located in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Project Acquisition

6 Aug 2013 07:00

RNS Number : 9940K
Bluefield Solar Income Fund Limited
06 August 2013
 

06 August 2013

 

BLUEFIELD SOLAR INCOME FUND LIMITED

(the "Fund" or "BSIF")

 

First Project Acquisition

 

 

Bluefield Solar Income Fund Limited is pleased to announce that it has entered into binding contracts to acquire a large-scale solar plant in Oxfordshire for total investment consideration of £12 million. The agricultural site located near Abingdon will be one of the largest in the region. The plant, expected to commence electricity generation during October 2013, is being constructed by Ikaros Solar ("Ikaros"), a leading Belgian solar contractor.

 

Following the sale of the project, under the terms of the contract, Ikaros will warrant the performance of the plant for an initial period and will undertake the ongoing operation and maintenance of the plant under a separate O&M agreement.

 

The investment has been made without debt financing and the expected returns on this investment are in line with those anticipated in the Fund's investment objective as set out in its prospectus dated 25 June 2013.

 

Giovanni Terranova, a partner at Bluefield Partners LLP, BSIF's Investment Adviser, said "The transaction with Ikaros typifies the investment characteristics sought by the Fund: large-scale solar assets providing the opportunity for its investors to get long-term, stable and index-linked revenues, all underpinned by strong performance guarantees from a proven solar contractor."

 

Mike Carter, Managing Director of Ikaros Solar UK said "The closing of the sale of the solar plant to Bluefield represents the third construction and sale of a large-scale UK solar asset by Ikaros Solar in the UK in the last four months. We are pleased that our asset has been selected as the first acquisition by the UK solar industry's primary listed Fund"

 

Enquiries:

 

James Armstrong

Mike Rand

Giovanni Terranova

Bluefield Partners LLP

Tel: +44 (0)20 7078 0020

 

Tod Davis / David Benda

Numis Securities Limited - Broker

Tel: +44 (0)20 7260 1000

 

Kevin Smith

Heritage International Fund Managers Limited - Company Secretary & Administrator

Tel: +44 (0)1481 716000

 

 

Note to editors

 

Bluefield Solar Income Fund Limited is a newly incorporated Guernsey-registered investment fund focusing on large scale agricultural and industrial solar assets, which raised gross proceeds of £130 million in June 2013 through an initial public offering ("IPO") of shares on the main market of the London Stock Exchange.

The Fund seeks to provide Shareholders with an attractive return, principally in the form of semi-annual income distributions, by investing in a diversified portfolio of solar energy assets, each located within the UK, with a focus on utility scale assets and portfolios on greenfield, industrial and/or commercial sites.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEELFBXVFXBBD
Date   Source Headline
2nd Oct 20234:47 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSDirector Retirement and New Audit Chair
28th Sep 20237:01 amRNSFourth Interim Dividend
28th Sep 20237:00 amRNSAnnual Report for the Year Ended 30 June 2023
13th Sep 20232:40 pmRNSHolding(s) in Company
5th Sep 20233:27 pmRNSHolding(s) in Company
24th Aug 202312:47 pmRNSDirector/PDMR Shareholding
23rd Aug 20235:03 pmRNSDirector/PDMR Shareholding
18th Aug 202312:10 pmRNSDirector/PDMR Shareholding
18th Aug 202312:08 pmRNSDirector/PDMR Shareholding
17th Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSUnaudited Net Asset Value as of 30 June 2023
7th Aug 202312:12 pmRNSThird Interim Dividend Announcement - Replacement
7th Aug 20237:00 amRNSThird Interim Dividend Announcement
22nd Jun 20237:00 amRNSRCF Increase and Extension
7th Jun 20237:00 amRNSConclusion of Audit Tender Process
18th May 20235:21 pmRNSChange to Director Roles and Responsibilities
11th May 20237:00 amRNSUnaudited NAV 31 Mar 2023 and 2nd Interim Dividend
2nd May 20237:00 amRNSRe-Financing, Increase & Extension of NatWest Loan
17th Mar 20239:44 amRNSDirector Declaration
8th Mar 20237:00 amRNSChange of Registrar
28th Feb 20237:00 amRNSInterim Results to 31 December 2022
22nd Feb 20233:28 pmRNSDirector Retirement
6th Feb 20237:00 amRNSNotice of Interim Results
23rd Jan 20237:00 amRNSFirst Interim Dividend
12th Jan 202312:32 pmRNSUpdate research from QuotedData
9th Jan 20233:32 pmRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSAcquisition of 46.4MWp Solar Portfolio
8th Dec 20225:45 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:52 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSChange to Director Roles & Responsibilities
29th Nov 20224:32 pmRNSResult of AGM
22nd Nov 20227:00 amRNSSept 22 NAV, Autumn Statement & Development Update
1st Nov 20227:00 amRNSNotice of AGM
20th Oct 20222:20 pmRNSDirector/PDMR Shareholding
17th Oct 20223:01 pmRNSDirector/PDMR Shareholding
14th Oct 20224:27 pmRNSDirector/PDMR Shareholding
14th Oct 20222:03 pmRNSDirector/PDMR Shareholding
13th Oct 20225:02 pmRNSDirector/PDMR Shareholding
7th Oct 20221:37 pmRNSDirector Appointment
6th Oct 20221:57 pmRNSDirector/PDMR Shareholding
4th Oct 20221:59 pmRNSDirector/PDMR Shareholding
3rd Oct 20223:56 pmRNSDirector/PDMR Shareholding
30th Sep 20225:11 pmRNSDirector/PDMR Shareholding
30th Sep 20227:01 amRNSFourth Interim Dividend Announcement
30th Sep 20227:00 amRNSAnnual Report for the Year Ended 30 June 2022
29th Sep 20227:00 amRNSChange to Director Roles and Responsibilities
23rd Sep 20227:00 amRNSPromotion to the FTSE 250
23rd Sep 20227:00 amRNSPromotion to the FTSE 250
22nd Sep 202210:49 amRNSDirector Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.